Six Technologies Emerging in the Quest for Cognitive Immortality

The question of human identity has long been tied to the three-pound organ inside the human skull, containing billions of neurons and trillions of synaptic connections. While cognitive continuity maintains our sense of self through decades of aging, death inevitably ends that biological process. Now, a growing circle of researchers and technologists—often termed "mind savers"—are investigating whether modern science can extend, preserve, or upload consciousness.

An examination of current research highlights six distinct technological approaches aiming to achieve cognitive immortality, ranging from practical near-term tools to speculative bioengineering.

1. Head Transplants and Spinal Reconnection

The concept of grafting a human head onto a donor body has lingered since 1970, when neurosurgeon Robert White transplanted a rhesus monkey's head at Case Western Reserve University. While the monkey survived for hours and moved its eyes and mouth, it lacked body control due to severed spinal nerves.

Controversial Italian surgeon Sergio Canavero has long championed human head transplantation. Canavero recently coauthored a study in the journal PLOS One with researchers from Moscow's Sklifosovsky Research and Clinical Institute for Emergency Medicine. In the experiment, the team severed the spinal cords of three pigs and rejoined them using a chemical surgical sealant, reporting that the animals regained the ability to stand and walk unsteadily.

Despite these claims, the broader scientific community remains skeptical. Grégoire Courtine, a spinal rehabilitation specialist at the École Polytechnique Fédérale de Lausanne in Switzerland, dismissed the concept entirely, noting that no existing technology is capable of achieving functional human body transplantation.

2. AI Mindclones and Generative Avatars

Rather than preserving physical tissue, some look toward software. In 2014, biotech executive Martine Rothblatt proposed "mindclones"—conscious digital avatars constructed from personal data such as diaries, recordings, and social media histories.

Today, commercial platforms including StoryFile, Afterlife AI, and Synthesia offer consumer-facing software that converts personal data into conversational bots and video avatars. Influencers use them to offload content creation, while families employ them to retain interactive digital memories of aging relatives. During a 2025 event at UCLA titled "The Bridge to Humanizing AI," Rothblatt demonstrated "Marvatar," a digital avatar that co-led discussions alongside her physical self.

However, these avatars remain advanced mimicry rather than conscious beings. Neuroscientists still lack a clear definition or empirical test for subjective self-awareness, leaving whether an avatar can ever experience true consciousness an open debate.

3. Disembodied Brains in Life-Support Perfusion

Sustaining extracted biological brains in artificial fluid environments has entered real-world laboratories. Startup Bexorg has displayed human brains obtained from organ donors, maintaining them in vats using oxygen-rich artificial blood.

According to Bexorg CEO Zvonimir Vrselja, the primary utility of these intact, metabolically active human brains is pharmaceutical testing, offering a more reliable testbed for Alzheimer's compounds than animal models. The company emphasized that coordinated electrical activity is absent in these brains, ruling out consciousness; researchers also administer the anesthetic propofol as a safeguard. Currently, such systems can keep disembodied brains metabolically functioning for roughly 24 hours, with the company aiming to extend that window to two weeks.

4. Gradual Brain Tissue Replacement

Instead of replacing the entire body or building an external clone, another approach involves replacing worn-out neural tissue piece by piece. In 2026, the US Advanced Research Projects Agency for Health (ARPA-H) backed this concept by allocating up to $175 million to FRONT (Functional Repair of Neocortical Tissue).

The initiative is led by neuroscientist Jean Hébert, who detailed gradual cell replacement in his 2020 book Replacing Aging. The program's formal clinical target is engineering laboratory-grown cortex to reverse stroke damage over a five-year development timeline. However, Hébert's broader vision calls for manufacturing embryonic-like neocortical precursor tissue to be grafted into adult brains gradually, allowing remaining brain networks time to integrate without resetting memories or identity. Stanford University stem-cell researcher Marius Wernig confirmed ARPA-H's specific interest in complex, functional cortex chunks rather than single isolated cell types.

5. Whole-Brain Emulation and Connectomics

The upload hypothesis relies on connectomics: the belief that individual memories and identities are encoded in the brain's complete wiring diagram. Princeton neuroscientist Sebastian Seung helped validate connectome mapping techniques by participating in an effort that successfully mapped 139,255 neurons and roughly 55 million synapses in a fruit fly brain using electron microscopy slicing and image-analysis software.

Achieving the same feat for a human brain—enabling a server-run digital mind—remains far out of reach. A 2025 survey of 312 neuroscientists published in PLOS One estimated that whole-brain emulation will not be technically feasible until at least 2125.

Anticipating that distant future, companies such as Nectome and Sparks Brain Preservation offer chemical fixation services to stabilize human neural tissue immediately after death. Both firms have explored partnering with terminally ill individuals utilizing medical aid in dying across the 13 US states and Washington, DC where the practice is legal, aiming to flash-preserve neural architecture at the exact moment of clinical demise. Both companies report they are still waiting for their first client under these programs.

6. Biohybrid Interfaces and Synthetic Neocortexes

A final pathway blends biology with computing hardware. Futurist Ray Kurzweil has argued that human intelligence could expand by connecting biological brains to a cloud-based "synthetic neocortex."

In 2024, California-based Science Corporation developed a biohybrid brain-computer interface by growing living nerve cells directly onto a microchip. Placed on an animal brain, these cultured cells grew axons that integrated into host neural pathways, establishing bidirectional computer-to-brain communication. Science Corporation CEO Max Hodak suggested such interfaces could direct dopamine production to treat Parkinson's disease, or serve as an externalized cranial pathway connecting human neural systems to external computing.

Stealth startup Eightsix Science, founded by Daniel Burger, is pursuing a hybrid method: gradually replacing biological neurons with biohybrid hardware while keeping the host functional. Burger contends that simulated software uploads will never be conscious, arguing instead that gradual hardware migration is the only viable path to non-biological human persistence.